YB-1 alters MT1-MMP trafficking and stimulates MCF-7 breast tumor invasion and metastasis

Biochemical and Biophysical Research Communications

Volumn 398, Issue 3, 2010, Pages 482-488

  Lovett, David H ^a   Cheng, Sunfa ^a   Cape, Leslie ^a   Pollock, Allan S ^a   Mertens, Peter R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Breast cancer; Cold shock protein; Invasion; Metastasis; MT1 MMP; YB 1

Indexed keywords

MATRIX METALLOPROTEINASE 14; Y BOX BINDING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER INVASION; CELL MIGRATION; CELL SURFACE; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DISTANT METASTASIS; ENDOCYTOSIS; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN TRANSPORT; TRANSGENE;

ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 14; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; PROTEIN TRANSPORT;

EID: 77955268515     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.104     Document Type: Article

References (20)

1. Didier D.K., Schiffenbauer J., Woulfe S.L., et al. Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc. Natl. Acad. Sci. USA 1988, 85:7322-7326.
2. Kohno K., Izumi H., Uchiumi T., et al. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 2003, 25:691-698.
3. Wu J., Lee C., Yokom D., et al. Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2. Cancer Res. 2006, 66:4872-4879.
4. En-Nia A., Yilmaz E., Klinge U., Lovett D.H., Stefanidis I., Mertens P.R. Transcription factor YB-1 mediates DNA polymerase alpha gene expression. J. Biol. Chem. 2005, 280:7702-7711.
5. Mertens P.R., Harendza S., Pollock A.S., Lovett D.H. Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J. Biol. Chem. 1997, 272:22905-22912.
6. Evdokimova V., Ruzanov P., Imataka H., et al. The major mRNA-associated protein YB-1 is a potent 5' cap-dependent mRNA stabilizer. Embo J. 2001, 20:5491-5502.
7. Raffetseder U., Frye B., Rauen T., et al. Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection. J. Biol. Chem. 2003, 278:18241-18248.
8. Chernov K.G., Mechulam A., Popova N.V., et al. YB-1 promotes microtubule assembly in vitro through interaction with tubulin and microtubules. BMC Biochem. 2008, 9:23.
9. Ruzanov P.V., Evdokimova V.M., Korneeva N.L., et al. Interaction of the universal mRNA-binding protein, p50, with actin: a possible link between mRNA and microfilaments. J. Cell Sci. 1999, 112(Pt 20):3487-3496.
10. Jia Z., Barbier L., Stuart H., et al. Tumor cell pseudopodial protrusions. Localized signaling domains coordinating cytoskeleton remodeling, cell adhesion, glycolysis, RNA translocation, and protein translation. J. Biol. Chem. 2005, 280:30564-30573.
11. Bergmann S., Royer-Pokora B., Fietze E., et al. YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification. Cancer Res. 2005, 65:4078-4087.
12. Habibi G., Leung S., Law J.H., et al. Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes. Breast Cancer Res. 2008, 10:R86.
13. Hotary K.B., Allen E.D., Brooks P.C., et al. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003, 114:33-45.
14. Sounni N.E., Devy L., Hajitou A., et al. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J. 2002, 16:555-564.
15. Mertens P.R., Alfonso-Jaume M.A., Steinmann K., Lovett D.H. A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. J. Biol. Chem. 1998, 273:32957-32965.
16. Bargou R.C., Jurchott K., Wagener C., et al. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat. Med. 1997, 3:447-450.
17. Turck J., Pollock A.S., Lee L.K., Marti H.-P., Lovett D.H. Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. J. Biol. Chem. 1996, 271:15074-15083.
18. Remacle A., Murphy G., Roghi C. Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface. J. Cell Sci. 2003, 116:3905-3916.
19. Dong J., Akcakanat A., Stivers D.N., et al. RNA-binding specificity of Y-box protein 1. RNA Biol. 2009, 6:59-64.
20. Bravo-Cordero J.J., Marrero-Diaz R., Megias D., et al. MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway. Embo J. 2007, 26:1499-1510.